Illumina Chosen to Help Bring Precision Medicine into Everyday Healthcare in Singapore
Published
Illumina, a global leader in DNA sequencing and genomics, has been selected to help bring precision medicine into everyday healthcare in Singapore. Precision medicine is a way of treating patients based on their genes, so that doctors can choose treatments that are more likely to work for each person.
Illumina says its work focuses on unlocking the power of the genome to improve human health. The company describes its focus on innovation as the reason it has become a leading provider of DNA technology around the world. Its selection means that its tools and expertise may be used to support the wider adoption of genomic testing in Singapore's healthcare system.
The move is part of a broader effort to make advanced medical technology more available to ordinary patients, not only to those in specialist research. For Singapore readers, this could mean that genetic tests become a more common part of diagnosis and treatment in the future. Further details about the scope and timeline of the project were not included in the available information.
The development shows how Singapore continues to invest in healthcare innovation. As genomic medicine develops, patients and healthcare workers are likely to hear more about how DNA information is used in their care.
Sources: Illumina
More Singapore news
- Singapore Needs More Tech Companies to Grow Its Stock Market, HSBC Strategist Says
- Singapore Tech Shares Rebound After Last Week's Sell-Off
- Databricks Plans to Double Its Singapore Team to 500 Staff
- Visa Sets Up Six Technology Hubs in New Singapore Centre
- US Congress Faces Possible Impeachment Fight Over Defence Secretary Pete Hegseth
- Giving Former Politicians Room to Return to Normal Life in Singapore
- Singapore Cloud Firm Megaspeed Faces Renewed US Scrutiny
- Iran Calls for Stronger Economic and Trade Ties with Singapore